Ataluren
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
PTC Therapeutics
Overview
Ataluren is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
Ataluren clinical trials
Explore related
Medical disclaimer. This page summarizes research about Ataluren for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.